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INTERPRETATIVE SUMMARY 1 
 2 
Short Communication: 3 
Differential immunoglobulin transfer during mastitis challenge by pathogen-specific 4 
components. By Wellnitz et al. 5 
This study investigated the effects of the major pathogenic components lipopolysaccharide of 6 
E. coli and lipoteichoic acid of S. aureus on blood-milk barrier permeability. The transfer of 7 
immunoglobulins and lactate from blood into milk was measured during a quantitatively 8 
similar level of mammary inflammation, based upon SCC increase. The results show a more 9 
efficient transfer of the blood components IgG2 and lactate into milk after intramammary 10 
challenge with lipopolysaccharide from E. coli than with lipoteichoic acid from S. aureus. 11 
Such a pathogen-specific difference may play some role in the course and severity of mastitis. 12 
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Abstract  45 
Mastitis induced by E. coli is often characterized by severe clinical signs indicating a more 46 
powerful combat of the immune system against the pathogen compared to S. aureus infections 47 
that are often represented by chronic and subclinical diseases. The aim of this study was to 48 
test the major pathogenic components lipopolysaccharide (LPS) from E. coli and lipoteichoic 49 
acid (LTA) from S. aureus for their effects on blood-milk barrier integrity and the related 50 
transfer of immunoglobulins and lactate from blood into milk. A similar SCC increase was 51 
achieved by intramammary challenge of one quarter of five cows with 20µg of LTA, and 52 
eight cows with 0.2µg LPS (maximum log SCC/ml: 7). Milk immunoglobulin (Ig) G1 53 
concentrations increased in LPS but not in LTA challenged quarters. Milk IgG2 54 
concentrations were increased (P<0.05) in treated quarters at 3 h after LPS, and 6 h after LTA 55 
challenge. Higher maximum levels of IgG2 were reached in milk of LPS treated quarters 56 
(173±58 μg/ml) than of LTA challenged quarters (62±13μg/ml). IgG1 and IgG2 levels did not 57 
change in control quarters. L-lactate concentrations in milk increased 4 h after LPS and 5 h 58 
after LTA challenge and reached higher maximum levels in LPS (221±48 mg/L) than in LTA 59 
treated quarters (77±18mg/L). In conclusion, a mammary inflammation on a quantitatively 60 
similar level based on SCC increase achieves a more efficient transfer of blood components 61 
like IgG2 via the blood-milk barrier if induced by LPS from E. coli than by LTA from S. 62 
aureus. This pathogen-specific difference may play an important role in the cure rate of the 63 
respective intramammary infection which is usually lower in S. aureus than in E. coli induced 64 
mastitis. 65 
 66 
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Intramammary infection with E. coli usually causes acute clinical mastitis (Hogan and Smith, 71 
2003) indicating a powerful combat of the immune system against the pathogen. In contrast, 72 
intramammary S. aureus infections are often characterized by chronic and subclinical diseases 73 
(Sutra and Poutrel, 1994), and the pathogen seems to be able to prevent a significant activity 74 
of the immune system. Lipoteichoic acid (LTA) and lipopolysaccharide (LPS) are cell wall 75 
components of S. aureus and E. coli, respectively, which are generally accepted to be major 76 
bacterial components that induce the mammary immune defense. These cell wall components 77 
are experimentally used to investigate the mammary immune response (Schmitz et al., 2004; 78 
Werner-Misof et al., 2007; Rainard et al., 2008). Choosing dosages to standardize the immune 79 
response quantitatively based on a similar SCC increase allowed the study of qualitative 80 
differences between these pathogenic components (Wellnitz et al., 2011). Differences in the 81 
induction of the mammary immune response by intramammary challenge with LPS and LTA 82 
were shown by a different induction of expression of different immune factors (Wellnitz et 83 
al., 2011), which most likely plays a role in the development of different mastitis severities. 84 
During the inflammation of the mammary gland a massive leakage of blood constituents into 85 
milk occurs due to blood milk barrier alteration (Burton and Erskine, 2003). Besides SCC, the 86 
concentrations of a number of other parameters increase in milk in response to inflammation 87 
of the mammary gland. Not all of these parameters may contribute to the immune response. 88 
Immunoglobulin (Ig) G is the major immunoglobulin in ruminant milk (Butler, 1983). The 89 
subclass IgG1 is the predominant antibody type in milk from healthy quarters because of an 90 
active, selective IgG1 transport across the blood milk barrier via the FcRn receptor system 91 
(Baker et al., 2009). In mastitic milk IgG2 becomes the predominant antibody (Caffin and 92 
Poutrel, 1988). It is considered to be the main opsonin supporting neutrophil phagocytosis in 93 
the bovine mammary gland, and is, therefore, playing an important role in the combat against 94 
mastitis pathogens (Burton and Erskine, 2003).  95 
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L-Lactate (hereafter referred to as lactate) is another blood component that increases in milk 96 
during mastitis and is proposed to be used as an early indicator to detect mastitis (Davis et al., 97 
2004). Leukocytes as a source of lactate in milk during an immune response has been 98 
considered (Davis et al., 2004). Recently we described the blood as a major source of milk 99 
lactate that leaks into milk as a result of the impairment of the blood-milk barrier during the 100 
immune response (Lehmann et al., in press). 101 
The aim of this study was to investigate the transfer of immunoglobulins and lactate from 102 
blood into milk due to a change of the blood-milk barrier integrity after an intramammary 103 
challenge with LPS from E. coli and LTA from S. aureus with a comparable SCC increase in 104 
milk. 105 
In 13 dairy cows a similar SCC increase (maximum log SCC/ml 7) was achieved by 106 
intramammary challenge of one quarter with 20µg of LTA (n=5) from a S. aureus strain that 107 
induced a chronic bovine mastitis, or with 0.2µg LPS (n=8) from E. coli that induced an acute 108 
bovine mastitis, as previously described (figure 1; Wellnitz et al., 2011). In hourly taken 109 
plasma (jugular vein) and milk samples (~10 mL) from challenged and control quarters, IgG1 110 
and IgG2 concentrations were analyzed using ELISA (Bovine IgG1/IgG2 ELISA Quantitation 111 
Set; Bethyl Laboratories Inc., LuBioScience, Luzern, Switzerland). The procedure was 112 
performed according to manufacturer’s protocol. A blocking reagent consisting of fish gelatin 113 
[1ml of fish skin gelatin (G7765; Sigma Aldrich, Steinheim, Germany) in 20ml of bidistilled 114 
water] was used to avoid matrix effects. Coefficients of variations, calculated by using a 115 
control sample on each plate, was 10 and 20% within, and between assays, respectively. 116 
Lactate concentrations were measured using the test kit Lactate PAP (bioMérieux, Marcy 117 
l`Etoile, France) with an automated analyzer (COBAS MIRA, Roche Diagnostics, 118 
Switzerland) according to manufacturer’s instructions.  119 
Data are presented as means ± SEM. Lactate concentrations are presented and statistically 120 
evaluated on a logarithmic scale (log10) to ensure normal distribution. Differences within 121 
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treatment group to time point 0 and between LPS and LTA treatments within each time point 122 
(hourly) were tested for significance (P < 0.05) by ANOVA using a MIXED procedure of 123 
SAS (1999–2001, release 8.02; SAS Institute Inc., Cary, NC). The model included time, 124 
treatment, and their interaction as fixed effects, and quarter within cow as repeated subject. A 125 
Tukey-Kramer adjustment was used to compensate for multiple comparisons. The significant 126 
(P < 0.001) Pearson’s correlation coefficient (SigmaPlot v11, Systat Software Inc.) between 127 
SCC and IgG1 and IgG2 in LPS challenged quarters was 0.42 and 0.33, respectively, and 0.45 128 
and 0.68 between SCC and IgG1 and IgG2 in LTA challenged quarters, respectively. 129 
In blood IgG1 and IgG2 concentrations were 16.5±1.1 mg/mL and 35.4±6.8 mg/mL, 130 
respectively, and did not change throughout the experiment. Although IgG concentratios in 131 
serum are know to be variable due to different factors like age and lactational stage (Mallard 132 
et al., 1983) this are relatively high values compared to other studies where concetrations 133 
around 10mg/mL are found for both Ig (Butler, 1983; Caffin and Poutrel, 1988). Reasons for 134 
that remain unclear. The test kits were validated according manufacturers recommendation. 135 
Milk IgG1 concentrations (figure 2 A) were 68±6, 63±5, and 83±12 µg/mL in control, LPS 136 
and LTA challenged quarters before (0 h) challenge, respectively. In LPS challenged quarters 137 
IgG1 concentrations increased at 4 and 5 h and from 7 h after challenge until the end of the 138 
experiment. The maximum of 105±13 µg/mL was reached 5 h after challenge. In control and 139 
in LTA challenged quarters milk IgG1 concentrations did not significantly increase. 140 
Milk IgG2 concentrations (figure 2 B) were 30±6, 32±8, and 23±8 µg/mL, in control, LPS and 141 
LTA challenged quarters before (0 h) challenge, respectively. Milk IgG2 concentrations 142 
increased at 3h in LPS challenged quarters, reached the maximum of 173±58 μg/mL at 6 h 143 
after challenge, and stayed elevated until the end of the experiment. In LTA challenged 144 
quarters IgG2 was increased at 6 h, reached a maximum of 67±9 µg/mL at 8 h and stayed 145 
elevated until 11 h after challenge. In control quarters milk IgG2 concentrations did not 146 
significantly increase.  147 
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The present study clearly shows that LPS of E. coli obviously opens the blood-milk barrier to 148 
a greater extent than LTA from S. aureus despite a similar SCC increase in response to both 149 
treatments. This mechanism could be involved in the mainly chronic development of mastitis 150 
by S. aureus because an insufficient amount of antibodies and other immune factors from 151 
blood are transferred into milk due to a reduced opening of the blood-milk barrier induced by 152 
these bacteria.  153 
Concentrations of IgG2 in milk raised to a greater extend (5fold after LPS challenge) than 154 
IgG1 (3fold after LPS challenge) although these molecules have comparable molecular 155 
weights of approximately 160kDa (Butler, 1983) and should be able to pass the blood-milk 156 
barrier in a comparable way. The IgG1:IgG2 ratio in milk at 5 h after LPS challenge was 1:1.5 157 
while the ratio in blood was 1:2.1.  This is mainly due to the specific transport of IgG1 (Mayer 158 
et al., 2005) that was also responsible of a 2.5:1 ratio in milk before LPS challenge. In 159 
addition, a specific transport of IgG2 was discussed (Newby and Bourne, 1977) and binding of 160 
IgG2 to mammary epithelial cells has been reported (Sasaki et al., 1977). However, during 161 
lactation of the healthy mammary gland, a passive transfer of IgG2 from the blood is assumed 162 
(Guidry et al., 1980). 163 
As IgG2 plays a particular role in the mammary immune defense the availability of antibodies 164 
in the milk can be crucial for mastitis defense, specifically if antibodies against the invaded 165 
mastitis pathogens are available in the blood. Although IgG2 are also entering the milk bound 166 
to PMN (Butler, 1983) the majority of milk IgG2 that appear in milk during mammary 167 
inflammation leak into mammary gland from the blood (Burton and Erskine, 2003). That 168 
differences of the IgG2 content in the milk during mastitis can depend on the pathogen has 169 
been reported (Caffin and Poutrel, 1988). 170 
Lactate is another blood component whose appearance in milk was tested with the 171 
intramammary LPS or LTA challenge. Blood lactate concentration was 54.9±1.2 mg/L before 172 
LPS challenge and did not change throughout the experiment. Lactate concentrations in milk 173 
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(figure 3) were increased at four hours after challenge in LPS treated quarters and five hours 174 
after challenge in LTA treated quarters and both stayed elevated until the end of the 175 
experiment. At four hours after challenge until 11 h after challenge the lactate concentrations 176 
in milk were higher in LPS than in LTA treated quarters. This greater increase of lactate in 177 
milk of quarters challenged with LPS compared to quarters challenged with LTA also shows a 178 
different characteristic in the change of blood-milk barrier permeability in response to E. coli 179 
when compared to S. aureus endotoxin. The small molecular size (90Da) of lactate facilitates 180 
transfer from blood into milk. However, milk concentration of lactate increased to up to 4.0 181 
fold higher levels of those in blood (220.7±48.1 mg/L) at 8 h after LPS challenge and to 1.4 182 
fold (76.8±18.3 mg/L) 10 h after LTA challenge. This effect was seen before (Lehmann et al., 183 
in press). It was suggested to be due to an additional lactate production and release during 184 
anaerobic metabolism by milk and epithelial cells in the gland (Silanikove et al., 2011) and/or 185 
to be an effect of an additional transporter system for lactate, which could be via aquaporins, 186 
since aquaporins transport lactate (Conde et al., 2010), and aquaporins are present in the 187 
bovine mammary gland (Mobasheri et al., 2011).  188 
 189 
In conclusion, a mammary challenge equalized for SCC increases produces a greater, and 190 
differential permeability of the blood-milk barrier for immunoglobulin’s when induced by 191 
LPS from E. coli compared to LTA from S. aureus. Thus, a more efficient transfer of blood 192 
components like IgG2 is achieved with E. coli that predominatly induces acute and severe 193 
mastitis compared to LTA from S. aureus that is responsible for more chronic and subclinical 194 
mastitis. This effect could have an important influence on the cure rate of the respective 195 
intramammary infection, which is usually lower in S. aureus than in E. coli induced mastitis, 196 
specifically if antibodies against the mastitis pathogen are present in the blood, e.g after 197 
vaccination. 198 
 199 
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Figure Legends 265 
 266 
Figure 1: 267 
Milk SCC in LPS challenged quarters (□; n=8), in LTA challenged quarters (●; n=5), and in 268 
control quarters (x; n=13).  a, b, c: Means without common superscript letters are significantly 269 
different between groups within one time point (P <0.05). This graph was formerly published 270 
(Wellnitz et al. 2011). 271 
 272 
Figure 2: 273 
Milk immunoglobulin (Ig)G1 (A) and IgG2 (B) concentrations in LPS challenged quarters (□; 
n=8), in LTA challenged quarters (●; n=5), and in control quarters (x; n=13).  *: indicates the 
first and subsequent time points with a significant (P < 0.05) difference to time 0.  #: indicates 
significant (P < 0.05) differences between LPS and LTA challenged quarters within time 
point. 
 274 
Figure 3: 275 
Milk lactate concentrations in LPS challenged quarters (□; n=8), in LTA challenged quarters 
(●; n=5), and in control quarters (x; n=13). *: indicates the first and subsequent time point 
with a significant (P < 0.05) difference to time 0.  #: indicates significant (P < 0.05) 
differences between LPS and LTA challenged quarters within time point. 
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Figure 1; JDS 282 
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